PET and SPECT Molecular Imaging in Drug Development
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Radiopharmaceutical Sciences".
Deadline for manuscript submissions: 10 November 2024 | Viewed by 1257
Special Issue Editor
Interests: PET pharmacokinetics; molecular imaging research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Our forthcoming Special Issue of Pharmaceuticals, entitled “PET and SPECT Molecular Imaging in Drug Development”, will focus on the pivotal role of Positron Emission Tomography (PET) and SPECT (Single-photon emission computed tomography) in advancing drug development. Both, PET and SPECT imaging offer non-invasive insights into molecular processes, pharmacokinetics, and target engagement, enabling researchers to optimize drug candidates and predict clinical outcomes.
We are seeking contributions on topics such as novel tracers, preclinical and clinical applications, safety and efficacy assessments, quantitative data analysis, personalized medicine, and regulatory perspectives.
This Special Issue will serve as a platform for cutting-edge research, innovative methodologies, and case studies showcasing the impact of PET and SPECT imaging on drug development. We aim to create a bridge between academia and industry, fostering collaborations that translate PET- and SPECT-based discoveries into transformative therapies.
Dr. Hyun Soo Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.